Takeaway
Genetic screening of OPA3 mutations should be part of the differential diagnosis of peripheral neuropathy (PN), even in the absence of optic atrophy.
Why this matters
Patients with autosomal dominant optic atrophy and cataract (ADOAC/+) syndrome may be asymptomatic or could develop severe or disabling PN long after the onset of ophthalmologic issues.